Skip to main content
. 2020 Dec 14;12(12):3755. doi: 10.3390/cancers12123755

Table 2.

Detection of i(12p) or additional copies of chromosome 12 without i(12p) by fluorescence in situ hybridization (FISH) in primary tumors and SMNs.

Case No. Primary Testicular Tumor Age at Initial Diagnosis Primary Treatment Age at SMN Time to SMN (Yrs.) SMN Histology Metastatic Tumor % i(12p) FISH Positive # i(12p) Copies
1 Seminoma * 51 BEP 57 6.5 Unclassified sarcoma RP 56% 1–2
2 Seminoma 31 XRT 54 22.0 Colorectal Liver 68% 1
3 Seminoma 28 XRT, BEP, HDC + SCT 34 5.9 LMS Gluteus 64% 1–2
4 Seminoma 53 BEP 56 3.1 Urothelial Bladder 39% 1
5 Nonseminoma 39 BEP 39 0.4 Pancreatic Pancreas 63% 1–3
Case No. Primary Histology Age at Initial Diagnosis Primary Treatment Age at SMN Time to SMN (Yrs.) SMN Histology Site of SMN % Extra Copies Chromosome 12 # i(12p) Copies
6 Seminoma 33 XRT 51 18.0 LMS RP 73% 0
7 Seminoma 51 XRT 59 7.6 Rectal (adenocarcinoma) Rectum 55% 0
8 Seminoma 58 XRT 71 13.3 Colorectal Cecum 36% 0
9 Seminoma 57 XRT 65 8.5 Lung (adenocarcinoma) Lung 72% 0
10 Seminoma 29 XRT 59 24.6 Melanoma Axillary lymph node 83% 0
Nonseminoma 44 BEP
11 Seminoma 22 XRT 58 9.6 LMS RP 72% 0
12 Nonseminoma 28 CISCA/VB 45 36.3 LMS RP 74% 0
13 Seminoma 53 XRT 58 44.8 Colorectal Lung 83% 0
14 Seminoma 62 65 5.2 Lung (squamous) Lung 61% 0
15 Seminoma 27 XRT 81 3.0 Urothelial Bladder 66% 0
16 NA 20 XRT + VB 57 53.6 Adrenal Cortical Carcinoma Adrenal 89% 0
17 Seminoma 31 XRT 61 36.6 Bladder Bladder 82% 0
18 Seminoma 29 CTX/carboplatin 49 29.9 Urothelial Renal pelvis 51% 0
19 Seminoma 47 XRT 65 20.3 Renal cell carcinoma Kidney 57% 0
20 Seminoma 29 PVB 54 19.4 Urothelial Bladder 91% 0

BEP: bleomycin, etoposide, cisplatin. XRT: radiation therapy. HDC + SCT: high-dose chemotherapy + stem-cell transplantation. CEB: carboplatin, etoposide, bleomycin. PVB: cisplatin, vinblastine, bleomycin. CISCA: cyclophosphamide, doxorubicin, cisplatin. VB: vinblastine, bleomycin. CTX: cyclophosphamide. LMS: leiomyosarcoma. RP: retroperitoneum. * Diagnosed by biopsy of retroperitoneal lymph node. Pathology of primary tumor not available.